Skip to content
Product Line: Pharmaceutical Chemicals

Erythromycin

CAS 114-07-8

Molecular structure of Erythromycin

CAS · 114-07-8

01

Product Overview

Erythromycin is a high-purity a-api supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.

02

Product Specifications

Grade: USP-NF2024
Appearance: White or off-white crystals or powder, odorless, slightly hygroscopic
Spectroscopy identification tests - Infrared Spectroscopy: Meets the requirement
HPLC Identification: The retention times of erythromycin A, B, and C in the sample correspond to those of standard solutions
Assay: 85.0% - 100.5%
Erythromycin A (Ery-A): /
Erythromycin B (Ery-B): 12.0% max
Erythromycin C (Ery-C): 5.0% max
Residue on ignition: 0.2% max
Limit of thiocyanate: 0.3% max
Erythromycin A enol ether: 3.0% max
Largest single impurity: 3.0% max
Optical rotation: -71° ~ -78°
Water Determination: 10.0% max
Total Aerobic Microbial Count (TAMC): 10³ cfu/g max
Total Yeast and Mold Count (TYMC): 10² cfu/g max
03

Applications

1. Pharmaceutical and Medical Use

a. Treatment of Bacterial Infections

Erythromycin is used to treat a wide range of bacterial infections, including:

● Upper and lower respiratory tract infections (e.g., pharyngitis, pneumonia, bronchitis)

● Skin and soft tissue infections

● Ear infections (e.g., otitis media)

● Eye infections (e.g., conjunctivitis)

● Gastrointestinal infections, particularly those caused by Campylobacter jejuni

● Genital infections, including Chlamydia trachomatis and Mycoplasma genitalium

● Whooping cough (Bordetella pertussis)

It is particularly valuable for penicillin-allergic patients and is often used as an alternative to beta-lactam antibiotics.

b. Topical and Dermatological Use

● Erythromycin is widely used in topical formulations (creams, gels, solutions) for treating acne vulgaris.

● It works by reducing bacterial load (especially Cutibacterium acnes) and inflammation, which are central to acne pathogenesis.

● Often combined with other agents like benzoyl peroxide or tretinoin for synergistic effects.

c. Ophthalmic Preparations

● Erythromycin ophthalmic ointment is used to treat eye infections and as prophylaxis in newborns to prevent neonatal conjunctivitis caused by Neisseria gonorrhoeae or Chlamydia trachomatis.

d. Gastrointestinal Motility Agent

● Erythromycin丨CAS 114-07-8 has prokinetic effects due to its action on motilin receptors, and is sometimes used off-label to manage gastroparesis and delayed gastric emptying in critically ill patients.

2. Veterinary Medicine

● Erythromycin丨CAS 114-07-8 is used in the treatment of infections in livestock and poultry, especially respiratory infections caused by susceptible organisms.

● Also used in aquaculture, particularly in fish, to treat bacterial gill disease, fin rot, and systemic infections caused by Aeromonas or Vibrio species.

3. Biotechnology and Microbiological Research

● Erythromycin is used in microbiological studies as a selective agent in growth media to inhibit or control specific bacterial populations.

● In genetic engineering, erythromycin resistance genes are used as selectable markers in plasmid vectors to confirm successful transformation in bacteria.

04

Benefits

1. Broad-Spectrum Antibacterial Activity

● Erythromycin丨CAS 114-07-8 is effective against many Gram-positive bacteria, such as Streptococcus, Staphylococcus, and Corynebacterium species.

● It also targets atypical pathogens like Mycoplasma pneumoniae, Chlamydia spp., and Legionella pneumophila, which makes it valuable in treating atypical pneumonias.

2. Safe for Penicillin-Allergic Patients

● For individuals allergic to penicillins or cephalosporins, erythromycin is a safe and effective alternative, especially for treating respiratory and skin infections.

3. Well-Studied with Decades of Clinical Use

● Erythromycin has a long-established safety and efficacy profile, making it a reliable choice for many bacterial infections.

● Its use in pediatrics, ophthalmology, dermatology, and geriatrics is well documented.

4. Versatility of Formulations

● Available in oral tablets, capsules, suspensions, topical gels, injectable forms, and ophthalmic ointments, erythromycin offers flexibility in administration across age groups and medical conditions.

● Topical formulations reduce systemic side effects while effectively targeting skin infections.

5. Anti-Inflammatory Effects

● In dermatological applications, erythromycin exerts anti-inflammatory effects that are beneficial in reducing redness, swelling, and pus formation in acne and rosacea.

● These properties enhance its role in long-term acne management, especially in patients who cannot tolerate retinoids.

Resistance and Limitations

● Overuse and misuse of erythromycin have contributed to the emergence of resistant strains, especially among Staphylococcus aureus and Streptococcus pneumoniae.

● Resistance mechanisms include methylation of ribosomal binding sites, efflux pumps, and enzymatic degradation.

● For this reason, erythromycin is now less preferred for some infections unless susceptibility is confirmed.

Conclusion

Erythromycin丨CAS 114-07-8 remains a cornerstone macrolide antibiotic used in human and veterinary medicine, dermatology, ophthalmology, and microbiological research. Its efficacy against a wide range of bacterial pathogens, its anti-inflammatory properties, and its availability in multiple formulations contribute to its enduring utility.

Previous

Sodium Deoxycholate丨CAS 302-95-4

Next

Naproxen丨CAS 22204-53-1

05

Conclusion

A concise summary and suitability assessment for this product is available on request. Contact our team to discuss whether it fits your process and quality requirements.